Author

Sreenivasa Murthy

Observed name: S. Murthy

ORCID: 0000-0001-5571-7357

Observed ORCID: 0000-0001-5571-7357

OpenAlex ID: A5108686873

Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial

2023 · W Timothy Garvey, Juan P Frias, et al. · The Lancet · 865

Switching to once-weekly insulin icodec versus once-daily insulin glargine U100 in individuals with basal-bolus insulin-treated type 2 diabetes (ONWARDS 4): a phase 3a, randomised, open-label, multicentre, treat-to-target, non-inferiority trial

2023 · Chantal Mathieu, Björg Ásbjörnsdóttir, et al. · The Lancet · 149

Once-weekly insulin efsitora alfa versus once-daily insulin glargine U100 in adults with type 2 diabetes treated with basal and prandial insulin (QWINT-4): a phase 3, randomised, non-inferiority trial

2025 · Thomas Blevins, Dominik Dahl, et al. · The Lancet · 34

Oral Semaglutide and Heart Failure Outcomes in Persons With Type 2 Diabetes

2026 · Rodica Pop-Busui, Søren Rasmussen, et al. · JAMA Internal Medicine · 17

Rising cost of insulin: A deterrent to compliance in patients with diabetes mellitus

2022 · Abdul Hamid Zargar, Sanjay Kalra, et al. · Diabetes & Metabolic Syndrome Clinical Research & Reviews · 10

Oral Semaglutide and Change in Cardiovascular Risk Factors in High-Risk Type 2 Diabetes

2026 · Sharon L. Mulvagh, Silvio E. Inzucchi, et al. · JAMA Cardiology · 6

Understanding Patients’ Willingness to Pay for Biphasic Insulin Aspart 30/70 in a Pen Device for Type 2 Diabetes Treatment in an Out-of-Pocket Payment Market

2021 · Sreenivasa Murthy, Pankaj Aneja, et al. · PharmacoEconomics - Open · 6

CGM‐derived efficacy and overall safety of once‐weekly insulin efsitora alfa (efsitora) relative to day of administration in adults with type 2 diabetes

2026 · Thomas Martens, Tadej Battelino, et al. · Diabetes Obesity and Metabolism · 1

Multicenter, Phase 4 Clinical Study from India to Evaluate the Safety and Efficacy of Insulin Glargine 300 U/ml in Insulin-Naïve People with Type 2 Diabetes Uncontrolled on Oral Anti-hyperglycemic Drugs: SAFEGUARD Study

2025 · Viswanathan Mohan, Bipin Sethi, et al. · Diabetes Therapy · 1

Fixed-Dose Combination of Canagliflozin and Metformin as an Adjunct to Diet and Exercise in Indian Adults with Type 2 Diabetes Mellitus: Results from a Multicentric, Open-Label, Single-Arm, Phase IV Study

2024 · Mohan Magdum, A G Unnikrishnan, et al. · Journal of the Association of Physicians of India · 1

Once-Weekly Insulin Icodec vs Once-Daily Insulin Glargine U100 in Combination with Bolus Insulin in Individuals with Type 2 Diabetes on Basal-Bolus Regimens (ONWARDS 4)

2023 · Birgit Nicola, Chantal Mathieu, et al. · Diabetologie und Stoffwechsel

Pdb120 Understanding Patients' Willingness to Pay (wtp) for Biphasic Insulin Aspart 30/70 (biasp30) in a Flexpen® Device or Using a Penfill® for Type 2 Diabetes (t2d) Treatment in an Out-of-pocket Payments Market

2019 · S. Murthy, P. Aneja, et al. · Value in Health

Use of Anthropometric Variables, Lipid Profile and Serum Insulin as Predictors of Insulin Resistance in Metabolic Syndrome Subjects

2014 · Sreenivasa Murthy, H T Geethanjali, et al. · Indian Journal of Public Health Research & Development

Works count: 13

Citation count: 1,090

H-index: 6

I10-index: 5